NCT02153788View on ClinicalTrials.gov

Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia

PHASE4CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2010

Conditions

Insomnia

Interventions

DRUG

Temazepam

Temazepam 15 mg orally at bedtime

DRUG

Placebo

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT02153788 - Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia | Biotech Hunter | Biotech Hunter